MMY-3002: A Phase 3 Study Comparing Bortezomib-Melphalan-Prednisone (VMP) with Melphalan-Prednisone (MP) in Newly Diagnosed Multiple Myeloma
Unfortunately, we do not have a better description for this publication.
Unfortunately, we do not have a better description for this publication.
